Pharmaceutical & Drug Injury

Pharmaceutical & Drug Injury

We represent people harmed by pharmaceuticals, biologics, and treatments (including surgical interventions) when the risks were not adequately disclosed – or not disclosed at all. This includes failure-to-warn claims involving drugs such as GLP-1 medications (Ozempic, Wegovy, Mounjaro, and similar products) and other treatments where patients were not told about serious short- and long-term side effects—including gastroparesis, bowel obstruction, vision loss, and related injuries.

Manufacturers and, in some cases, prescribers have a duty to provide accurate information about material risks. When they fail to do so, and a patient is injured as a result, the law provides a path to accountability.

What we handle

  • Failure-to-warn claims involving GLP-1 drugs and other pharmaceuticals

  • Cases involving undisclosed or understated serious side effects

  • Related claims against manufacturers and, where appropriate, prescribing providers

  • Deceptive Trade Practices Act claims when the information given about the medical intervention was deceptive, inadequate, or unconscionable

If you or a family member has been injured by a drug and believe the risks were not properly disclosed, tell us about your case. We will review it and respond within 48 hours.